The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

Daniel was diagnosed with Guillain-Barré syndrome, a rare neurological disorder that occurs when a person's immune system ...

The FDA requires labeling changes to the prescribing information for Pfizer and GSK RSV vaccines to include warnings about the risk for GBS.

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

Scientists at the Garvan Institute of Medical Research have discovered how a viral infection causes autoimmune disease, ...

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...

The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and ...

has been updated to include a new warning regarding the risk of Guillain-Barré syndrome (GBS) following vaccination. To assess the risk of GBS with these vaccines, the FDA conducted a ...

A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...